Replies to post #192674 on Cytodyn Inc (CYDY)

[Scooter McCabe]

This is a myth.

1. "Big Pharma" can't steal anything. All it takes is for a CEO to say "no we don't accept your offer." It's not like Nader was on watch, guarding against thieves and mercenaries looking for the holy grail that people claim Leronlimab is.

2. What potential? We don't know if it works. We don't know if it will actually meet the FDA standards once it has a complete filing to turn in.

3. The right fighter? Committed fraud, lied to shareholders, failed to meet a single goal, gained the attention of the DOJ and SEC.

Nader is not the CEO the company needs.

[ClosetInvestor]

“X) without him big pharma would have stolen our company's Leronlimab”

NP stole leronlimab from you by focusing on compensation and promotion instead of on protocols and science.

[3X Charm]

Yes, much better Nader stole from shareholders, instead of sale to big pharma, as if there was ever a chance.

[HyGro]

BP has no interest in Leronlimab -- they've had decades to buy it for pocket change and NONE have even made an offer. Only Vyera, the worst pharma in the U.S. gave the company ANY money for a partnership (only $5 million) and they are taking 50% of the HIV revenue. Progenics could get now takers after Phase 2 trials were successful, they actually shelved if for years until Cytodyn paid a measly $3.5 million to buy the rights. Since then -- nothing from BP. No BP has bought or partnered with an OTC penny stock biotech drug company over the last decade. Why would a BP get tied up in the nightmare of an OTC that is insolvent, under SEC and DOJ investigation, under shareholder class action lawsuit and has pissed off the FDA. It is a train wreck that no other company would want to get entangled in.